Do not use SEMGLEE if it is colored or cloudy, or if you see particles in the solution
Retrieved from Karagiannis, T., Malandris, K., Avgerinos, I., et al
It targets the liver and adipose tissue to increase energy expenditure (thermogenesis) and promote the breakdown of stored fats
#Cardiology #ASCVD #ClinicalResearch #CardiovascularRisk #Obesity #EvidenceBasedMedicine #PrecisionMedicine Evolocumab can help attenuate the elevated risk of major adverse cardiovascular events that individuals with obesity and atherosclerotic cardiovascular disease (ASCVD) face, according to a prespecified analysis from the FOURIER trial published in #JACC
Participation in properly designed clinical trials, if available, represents the most appropriate way to access experimental therapies whilst contributing to the evidence base for future patients